MADRIGAL PHARMACEUTICALS, INC. 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Jun 30, 2017
Insider Transaction Report
Form 4
MILLIGAN DAVID V
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-06-29+10,000→ 10,000 totalExercise: $16.46Exp: 2027-06-29→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The option vests 100% on the first anniversary of the date of grant, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.